Lv11
18 积分 2024-06-10 加入
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
5小时前
待确认
Oral Semaglutide 25 mg in Adults with Overweight or Obesity
5小时前
已完结
Advanced Prediction of Heart Failure Risk in Elderly Diabetic and Hypertensive Patients Using Nine Machine Learning Models and Novel Composite Indices: Insights from NHANES 2003-2016
8天前
已完结
Calorie Restriction with or without Time-Restricted Eating in Weight Loss
8个月前
已完结
Once-Weekly Semaglutide in Adults with Overweight or Obesity
9个月前
已完结
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity
9个月前
已完结
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes The STEP 8 Randomized Clinical Trial
9个月前
已完结
以甲状腺激素受体β为靶点治疗非酒精性脂肪性肝病的新进展题录
9个月前
已完结
Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial
10个月前
已完结
A new treatment and updated clinical practice guidelines for MASLD
10个月前
已完结
皖公网安备34019202002308
